Hormone Replacement Therapy Market To Witness Growth Rapidly Due To Large Presence Of Unmet Healthcare Needs In Emerging Economies Till 2022: Grand View Research, Inc.
Global hormone replacement therapy market is expected to
reach USD 28.4 billion by 2022, according to a new report by Grand View
Research, Inc. Increasing geriatric and neonatal population base, growing cases
of hormonal imbalances, and large presence of unmet healthcare needs in
emerging economies are some vital impact rendering drivers.
Estrogen
replacement therapy dominated the market in 2015. Moreover, the rising number
of women reaching the menopausal age is expected to drive the demand for these
treatments over the forecast period.
Furthermore,
rise in premature births that lead to genital disorders and slower rate of
growth in these neonates are anticipated to fuel the demand for growth hormone
therapy. According to statistics provided by the CDC, over 15 million babies
were born preterm in 2014 annually. This number is anticipated to rise over the
next seven years and become a leading cause for disabilities, illnesses,
arrested development, and mortality.
North
America hormone replacement therapy market share, by product, 2012-2022 (USD
Million)
Browse full
research report on Hormone Replacement Therapy Market: http://www.grandviewresearch.com/industry-analysis/hormone-replacement-therapy-market
Further key
findings from the report suggest:
- Estrogen therapy is expected to dominate the
product segment and hold over 50.0% of the market share by 2022. This
growth can be attributed to the increasing focus of healthcare bodies such
as the Women’s Health Initiative, The North America Menopause Society, and
The British Menopause Society, on providing safe replacement therapy.
- The parenteral route of administration is
commonly used for delivery of drugs such as Nutropin, Signifor,
Genotropin, and Tev-Tropin. Other routes such as pen-based delivery
systems and implants are gaining popularity owing to higher patient
comfort and ease-of-use. Furthermore, technological advancements in the
field providing higher bioavailability of drug and needle-free
administration are predicted to positively impact growth.
- Menopause and their vasomotor symptoms are
expected to be the most prevalent disease over the forecast period owing
to increasing number of women approaching the menopausal age. The segment
is predicted to hold about 40.0% of the market share by 2022.
- North America, particularly the U.S. dominated
the market and held about 35.0% of the total revenue in 2015. Existence of
well-regulated healthcare system and presence of a large pool of target
population are a few factors that promote growth. Countries such as South
Africa, China, India, and Brazil are anticipated to witness lucrative
growth over the forecast period, with China predicted to have the fastest
growth of over 10.0%.
- Some key companies catering to hormone
replacement therapies include Pfizer, Inc., Merck Serono, Novo Nordisk,
Eli Lilly, Bayer Healthcare, Mylan Laboratories, Amgen, Novartis, and
Genentech. Introduction of new formulations and development of innovative
drug delivery systems are expected to be a few initiatives taken by these
players over the forecast period.
Browse more
reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the hormone replacement therapy market
on the basis of product, route of administration, disease type, and
region
Hormone
Replacement Therapy Market Product Outlook (Revenue, USD Million, 2012 - 2022)
- Estrogen
Replacement Therapy
- Human
Growth Hormone Replacement Therapy
- Thyroid
Replacement Therapy
- Other
Hormone
Replacement Therapy Market Route Of Administration Outlook (Revenue, USD
Million, 2012 - 2022)
- Oral
- Parenteral
- Transdermal
- Other
Hormone
Replacement Therapy Market Type Of Disease Outlook (Revenue, USD Million, 2012
- 2022)
- Menopause
- Hypothyroidism
- Male
Hypogonadism
- Growth
Hormone Deficiency
- Other
Hormone
Replacement Therapy Market Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
- Saudi
Arabia
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-hormone-replacement-therapy-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment